Steps Towards Osteoarthritis Prevention
STOP
2 other identifiers
interventional
56
1 country
1
Brief Summary
Optimal knee joint loading, which refers to the forces acting on the knee caused by daily activities such as daily steps, plays an essential role in maintaining knee articular cartilage health and reducing the risk of osteoarthritis (OA). After anterior cruciate ligament reconstruction (ACLR), individuals take fewer daily steps as compared to uninjured controls resulting in insufficient knee joint loading to joint tissues, but it is unclear how changes in daily steps impact knee joint cartilage health in OA development. Therefore, the overall single arm, longitudinal pre-test post-test study objective is to determine the mechanistic links between knee joint loading as measured by daily steps and comprehensive magnetic resonance imaging (MRI) measures of knee joint cartilage health post-ACLR. The central hypothesis is that individuals post-ACLR who take low daily steps will demonstrate deconditioned, less resilient cartilage characterized by poor tibiofemoral cartilage composition and greater cartilage strain.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Sep 2024
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 21, 2023
CompletedFirst Posted
Study publicly available on registry
January 5, 2024
CompletedStudy Start
First participant enrolled
September 23, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 30, 2028
ExpectedStudy Completion
Last participant's last visit for all outcomes
January 30, 2028
April 29, 2026
April 1, 2026
3.4 years
December 21, 2023
April 23, 2026
Conditions
Outcome Measures
Primary Outcomes (17)
T2 relaxation times in the medial femoral condyle
MRI marker of T2 relaxation times of medial femoral articular cartilage (i.e collagen organization) at pre-intervention (baseline)
pre-intervention (baseline)
T2 relaxation times in the lateral femoral condyle
MRI marker of T2 relaxation times of lateral femoral articular cartilage (i.e collagen organization) at pre-intervention (baseline)
pre-intervention (baseline)
T2 relaxation times in the medial tibial condyle
MRI marker of T2 relaxation times of medial tibial articular cartilage (i.e collagen organization) at pre-intervention (baseline)
pre-intervention (baseline)
T2 relaxation times in the lateral tibial condyle
MRI marker of T2 relaxation times of lateral tibial articular cartilage (i.e collagen organization) at pre-intervention (baseline)
pre-intervention (baseline)
Change in T2 relaxation times in the medial femoral condyle
Change in MRI marker of T2 relaxation times of medial femoral articular cartilage (i.e collagen organization) from pre-intervention to post-intervention
pre-intervention (baseline), post-intervention (~18 weeks)
Change in T2 relaxation times in the lateral femoral condyle
Change in MRI marker of T2 relaxation times of lateral femoral articular cartilage (i.e collagen organization) from pre-intervention to post-intervention
post-intervention (~18 weeks)
Change in T2 relaxation times in the medial tibial condyle
Change in MRI marker of T2 relaxation times of medial tibial articular cartilage (i.e collagen organization) from pre-intervention to post-intervention
pre-intervention (baseline), post-intervention (~18 weeks)
Change T2 relaxation times in the lateral tibial condyle
Change in MRI marker of T2 relaxation times of lateral tibial articular cartilage (i.e collagen organization) from pre-intervention to post-intervention
pre-intervention (baseline), post-intervention (~18 weeks)
Average cartilage strain in the medial femoral condyle
MRI marker of cartilage strain (i.e., acute change in cartilage thickness/resting cartilage thickness) of medial femoral articular cartilage at pre-intervention (baseline)
pre-intervention (baseline)
Average cartilage strain in the lateral femoral condyle
MRI marker of cartilage strain (i.e., acute change in cartilage thickness/resting cartilage thickness) of lateral femoral articular cartilage at pre-intervention (baseline)
pre-intervention (baseline)
Average cartilage strain in the medial tibial condyle
MRI marker of cartilage strain (i.e., acute change in cartilage thickness/resting cartilage thickness) of medial tibial articular cartilage at pre-intervention (baseline)
pre-intervention (baseline)
Average cartilage strain in the lateral tibial condyle
MRI marker of cartilage strain (i.e., acute change in cartilage thickness/resting cartilage thickness) of lateral tibial articular cartilage at pre-intervention (baseline)
pre-intervention (baseline)
Change in average cartilage strain in the medial femoral condyle
Change in MRI marker of cartilage strain (i.e., acute change in cartilage thickness/resting cartilage thickness) of medial femoral articular cartilage from pre-intervention to post-intervention
pre-intervention (baseline), post-intervention (~18 weeks)
Change in average cartilage strain in the lateral femoral condyle
Change in MRI marker of cartilage strain (i.e., acute change in cartilage thickness/resting cartilage thickness) of lateral femoral articular cartilage from pre-intervention to post-intervention
pre-intervention (baseline), post-intervention (~18 weeks)
Change in average cartilage strain in the medial tibial condyle
Change in MRI marker of cartilage strain (i.e., acute change in cartilage thickness/resting cartilage thickness) of medial tibial articular cartilage from pre-intervention to post-intervention
pre-intervention (baseline), post-intervention (~18 weeks)
Change in average cartilage strain in the lateral tibial condyle
Change in MRI marker of cartilage strain (i.e., acute change in cartilage thickness/resting cartilage thickness) of lateral tibial articular cartilage from pre-intervention to post-intervention
pre-intervention (baseline), post-intervention (~18 weeks)
Daily steps
Average steps per day over 7 day physical activity monitor wear at pre-intervention (baseline)
Pre-intervention (baseline)
Other Outcomes (2)
Change in daily steps
Pre-intervention (baseline), post-intervention (~18 weeks)
Change in Knee Injury and Osteoarthritis Outcome Score Quality of Life subscale
Pre-intervention (baseline), post-intervention (~18 weeks)
Study Arms (1)
Interventional Group
EXPERIMENTALParticipants who meet study criteria and are enrolled in adaptive daily step promotion intervention
Interventions
Participants will wear a Fitbit monitor on their non-dominant wrist during a 10 to 14 day "run-in" screening to capture daily steps reported by the Fitbit but no daily step goals will be sent to the participant. The Fitbit monitor will be worn during all waking hours except water activities, and compliance will be considered as a day with ≥1,000 steps. Next, participants will undergo a 16-week intervention wearing the Fitbit monitor on their wrist and receive a text message each morning with a personalized, adaptive daily step count goal and a link used to confirm receipt of the goal. The preceding 10 days of step data will be rank ordered and the 60th percentile step count will be set as the goal for the next day. Goals will not exceed 10,000 daily steps.
Eligibility Criteria
You may qualify if:
- Provision of signed and dated informed consent form
- For children, signed and dated informed assent by child and parental permission form by parent/guardian to participate in the study
- Underwent an anterior cruciate ligament reconstruction (ACLR) between 6-60 months prior to enrollment
- Stated willingness to comply with all study procedures and lifestyle considerations and availability for the duration of the study
- Completed all other formal physical therapy and therapeutic exercise regimens, and will not be engaging in any other formal therapy for their ACLR during the study
- Physician clearance for unrestricted activity
- Owning a smartphone
- Demonstrate \< 8,000 steps per day during the screening phase of aim 2 as assessed using the Actigraph Link monitor
You may not qualify if:
- Underwent an ACLR revision surgery due to a previous anterior cruciate ligament (ACL) graft injury
- A multiple ligament surgery was indicated with their ACL injury
- A lower extremity fracture was suffered during the ACL injury
- The participant has previously been diagnosed with any diseases that affect joints is present in either knee including knee osteoarthritis inflammatory arthritis
- Pregnant or plans to become pregnant over next 4 months
- Body mass index (BMI) ≥ 36 kg/m2
- Unable to speak English
- Cochlear implant
- Metal in body (metal fragments, shrapnel, permanent make-up, body piercings that cannot be removed)
- Claustrophobia
- History of seizures
- Pacemaker
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Georgia
Athens, Georgia, 30602, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Caroline Lisee, PhD
University of Georgia
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 21, 2023
First Posted
January 5, 2024
Study Start
September 23, 2024
Primary Completion (Estimated)
January 30, 2028
Study Completion (Estimated)
January 30, 2028
Last Updated
April 29, 2026
Record last verified: 2026-04
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, ICF
- Time Frame
- Data will be available for 10 years once all formal data collection, processing, and primary analysis is complete.
- Access Criteria
- The data will be available to those who submit a formal written request to the PI and commit to only using the data for researcher purposes unplanned by the investigators.
Upon completion of the of the proposed projects, the overall data set will include outcome measures including: * Participant demographics * Knee injury history * ACLR surgical procedure data * Patient reported outcomes of self-reported knee function, physical activity, and psychological recovery * Daily steps throughout the intervention using a Fitbit * Daily steps before and after the intervention using a research grade tri-axial accelerometer * Habitual gait speed * Gait biomechanics at habitual gait speed * Magnetic resonance imaging (i.e., T1ρ, T2, and Dess)) of the tibiofemoral and patellofemoral joint All of the information will be linked together, but deidentified. The data will be available to those who submit a formal written request to the PI and commit to only using the data for researcher purposes unplanned by the investigators. The data cannot be used to recruit or contact participants and must be destroyed or returned following the data analysis.